Pipeline

Patented Contact Lens Drug Delivery Platform

Technology

Established Pipeline

1 Device
* R&D Collaboration

Widespread Advantages

MediPrint™
Value-added Benefits

For Patients
low cost/easy to use treatments, higher bioavailability, improved compliance, preservative-free, less side effects, complete solutions, non-invasive.

For Eye Care Professionals
low risk, non-invasive treatment choices, better patient outcomes, predictable treatment plans, fewer complications due to reduced side effect profiles, customized prescriptions, higher patient satisfaction, beneficial economics.

For Manufacturers
low cost/high quality products, low capital investment, reduced regulatory complexities, patent protection, first in market, deep pipeline of products.

For Payers
cost neutrality (versus prescription eye drops), more satisfied members and providers.